MarketPeel
Insider Trading Intelligence
GS

Gene Salkind

UPXI
DIRECTOR · UPEXI, INC. · CIK 0001592481
FILING MIX · LIFETIME100%/0%
BUYS
17
SELLS
0
TOTAL VALUE
$1.42M
COMPANIES
2
ACTIVE SINCE
Sep 2022
HOLDINGS NOW
231,911
AVG SELL PX
TRADE KIND
SHOWING 17 / 17
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
8 backtested trades · 8 horizons · 8 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Gene Salkind, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d8+75.00%+67.94%+1.75%+66.18%+7.83%
14d8+75.00%+53.31%+2.65%+50.66%+0.41%
30d8+25.00%+30.87%+2.56%+28.31%-12.79%
60d8+50.00%+39.96%+3.40%+36.56%-8.56%
90d8+50.00%+0.17%+6.44%-6.27%-27.75%
180d8+12.50%-23.23%+14.89%-38.13%-61.68%
1y8(3 pending)+0.00%-68.27%+27.94%-96.21%-105.66%
2y8(5 pending)+33.33%-22.34%+48.89%-71.23%-82.53%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
UPXI · 218,750 shares · as of Nov 20, 2025
0146,343292,685439,028585,370202320242025SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 17 buys / 0 sellsCOVERAGE · 15 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
COEP
COEPTIS THERAPEUTICS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
3,25013,161Feb 11, 2026Feb 13, 2026View →
COEP
COEPTIS THERAPEUTICS HOLDINGS, INC.
PURCHASE
5,700$10.56$60.2K13,161Feb 11, 2026Feb 13, 2026View →
UPXI
UPEXI, INC.
PURCHASE
50,000$2.55$127.5K218,750Nov 20, 2025Nov 21, 2025View →
UPXI
UPEXI, INC.
PURCHASE
100,000$2.81$281.0K168,750Nov 17, 2025Nov 18, 2025View →
UPXI
UPEXI, INC.
PURCHASE
100,000$2.65$265.0K569,470Nov 17, 2025Nov 18, 2025View →
UPXI
UPEXI, INC.
PURCHASEGRANT
Stock grant
150,000585,370Jul 16, 2025Jul 30, 2025View →
UPXI
UPEXI, INC.
PURCHASEGRANT
Stock grant
50,000435,370Jul 16, 2025Jul 30, 2025View →
UPXI
UPEXI, INC.
PURCHASE
20,243$4.94$100.0K385,370Jul 11, 2025Jul 30, 2025View →
UPXI
UPEXI, INC.
PURCHASE
241,229$2.28$550.0K365,127Apr 17, 2025Apr 24, 2025View →
UPXI
UPEXI, INC.
PURCHASEGRANT
Stock grant
35,00035,000Apr 17, 2025Apr 24, 2025View →
COEP
COEPTIS THERAPEUTICS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
5,7008,950Mar 4, 2025Mar 6, 2025View →
UPXI
UPEXI, INC.
PURCHASEGRANT
Stock grant
25,00025,000Jan 17, 2025Apr 24, 2025View →
COEP
COEPTIS THERAPEUTICS HOLDINGS, INC.
PURCHASE
11,600$0.69$8.0K284,056Jan 5, 2024Jan 9, 2024View →
COEP
COEPTIS THERAPEUTICS HOLDINGS, INC.
PURCHASE
4,006$1.01$4.0K4,046Aug 29, 2023Aug 30, 2023View →
COEP
COEPTIS THERAPEUTICS HOLDINGS, INC.
PURCHASE
28,638$0.91$26.1K28,638Aug 25, 2023Aug 30, 2023View →
COEP
COEPTIS THERAPEUTICS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
30,00030,000Jan 27, 2023Jan 31, 2023View →
UPXI
UPEXI, INC.
PURCHASEGRANT
Stock grant
50,00050,000Sep 30, 2022Nov 17, 2022View →
Other insiders · UPXI
Loading peer insiders…
About this filer
CIK 0001592481
ROLE
Director
PRIMARY
UPXI
COMPANIES
2
ACTIVE SINCE
Sep 2022
MARKETPEEL · /INSIDER/0001592481DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback